285 related articles for article (PubMed ID: 8679616)
41. Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers.
Jacques PS; Wöhrl BM; Howard KJ; Le Grice SF
J Biol Chem; 1994 Jan; 269(2):1388-93. PubMed ID: 7507107
[TBL] [Abstract][Full Text] [Related]
42. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase.
Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM
Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526
[TBL] [Abstract][Full Text] [Related]
44. Effects of donor and acceptor RNA structures on the mechanism of strand transfer by HIV-1 reverse transcriptase.
Hanson MN; Balakrishnan M; Roques BP; Bambara RA
J Mol Biol; 2005 Nov; 353(4):772-87. PubMed ID: 16216274
[TBL] [Abstract][Full Text] [Related]
45. An expanded model of replicating human immunodeficiency virus reverse transcriptase.
Wöhrl BM; Tantillo C; Arnold E; Le Grice SF
Biochemistry; 1995 Apr; 34(16):5343-56. PubMed ID: 7537089
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
[TBL] [Abstract][Full Text] [Related]
47. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.
Yusupova G; Lanchy JM; Yusupov M; Keith G; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
J Mol Biol; 1996 Aug; 261(3):315-21. PubMed ID: 8780773
[TBL] [Abstract][Full Text] [Related]
48. Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.
Kaushik N; Rege N; Yadav PN; Sarafianos SG; Modak MJ; Pandey VN
Biochemistry; 1996 Sep; 35(36):11536-46. PubMed ID: 8794733
[TBL] [Abstract][Full Text] [Related]
49. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
Kögel D; Aboud M; Flügel RM
Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
[TBL] [Abstract][Full Text] [Related]
50. Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3).
Smith JS; Roth MJ
J Biol Chem; 1992 Jul; 267(21):15071-9. PubMed ID: 1378844
[TBL] [Abstract][Full Text] [Related]
51. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
[TBL] [Abstract][Full Text] [Related]
52. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
Patel PH; Jacobo-Molina A; Ding J; Tantillo C; Clark AD; Raag R; Nanni RG; Hughes SH; Arnold E
Biochemistry; 1995 Apr; 34(16):5351-63. PubMed ID: 7537090
[TBL] [Abstract][Full Text] [Related]
53. A full-coordinate model of the polymerase domain of HIV-1 reverse transcriptase and its interaction with a nucleic acid substrate.
Setlik RF; Meyer DJ; Shibata M; Roskwitalski R; Ornstein RL; Rein R
J Biomol Struct Dyn; 1994 Aug; 12(1):037-60. PubMed ID: 7531452
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.
Jacobo-Molina A; Ding J; Nanni RG; Clark AD; Lu X; Tantillo C; Williams RL; Kamer G; Ferris AL; Clark P
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6320-4. PubMed ID: 7687065
[TBL] [Abstract][Full Text] [Related]
55. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase.
Cirino NM; Cameron CE; Smith JS; Rausch JW; Roth MJ; Benkovic SJ; Le Grice SF
Biochemistry; 1995 Aug; 34(31):9936-43. PubMed ID: 7543283
[TBL] [Abstract][Full Text] [Related]
56. Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes.
Metzger W; Hermann T; Schatz O; Le Grice SF; Heumann H
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5909-13. PubMed ID: 7687057
[TBL] [Abstract][Full Text] [Related]
57. Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain.
Beard WA; Stahl SJ; Kim HR; Bebenek K; Kumar A; Strub MP; Becerra SP; Kunkel TA; Wilson SH
J Biol Chem; 1994 Nov; 269(45):28091-7. PubMed ID: 7525566
[TBL] [Abstract][Full Text] [Related]
58. Contribution of the p51 subunit of HIV-1 reverse transcriptase to enzyme processivity.
Huang SC; Smith JR; Moen LK
Biochem Biophys Res Commun; 1992 Apr; 184(2):986-92. PubMed ID: 1374247
[TBL] [Abstract][Full Text] [Related]
59. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
[TBL] [Abstract][Full Text] [Related]
60. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.
Le Grice SF; Naas T; Wohlgensinger B; Schatz O
EMBO J; 1991 Dec; 10(12):3905-11. PubMed ID: 1718745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
